michael tal, md
Michael is an Assistant Professor of Radiology at the Yale University School of Medicine and creator of the Critical Care technology. He graduated from Hadassah Medical School in Jerusalem, Israel in 1995, and completed his training at MCP Hahnemann University in Philadelphia and Yale University. Dr. Tal, an expert in the field of vascular access, is a practicing Interventional Radiologist has been at Yale University since 1999. He is a clinician and researcher with numerous publications and over 30 presentations at national and international symposia.

michael cleman, md
Michael presently holds the title of Professor of Medicine at Yale University School of Medicine, and is the Director of the Cardiac Catheterization Laboratory and Interventional Cardiology programs at Yale New Haven Hospital. He has been an active participant in the field of intereventional cardiology being one of the original clinical investigators for coronary stents, and rotational atherectomy. He remains an active investigator in the area of interventional cardiac and vascular procedures. Dr. Cleman attended Johns Hopkins University from 1970 to 1973. He subsequently attended Johns Hopkins Medical School from 1973 to 1977, followed by completion of an internship and residency at Shands Teaching Hospital, University of Florida from 1977 to 1980. After completing his fellowship in cardiology at Yale University School of Medicine between 1980 and 1982 he remained on the academic faculty.

ronald jay solar, Ph.D.
Ronald Solar is CEO and a co-founder of ThermopeutiX, Inc. He has been designing and developing medical devices for over 25 years, and currently holds 37 United States Patents plus a significant number of foreign patents. In addition to his design and development skills, he has broad expertise in other areas crucial to a successful medical device company. Dr. Solar was a co-founder of three very successful medical device companies, Versaflex Delivery Systems, Inc. (acquired by Medtronic), Occam International, BV (intellectual property acquired by Cordis, operating company acquired by local management), and MEDgination, Inc. (merged with X Technologies and acquired by Guidant). He also played a key role in the successful start up of two other very successful medical device companies, SciMed Life Systems, Inc. (acquired by Boston Scientific) and Advanced Cardiovascular Systems, Inc. (acquired by Eli Lilly, now Guidant Corp.). In 1989, Dr. Solar was recognized by President George H. Bush as one of the Ten Outstanding Young Americans, and Junior Chamber International selected him as one of the Ten Outstanding Young People of the World for his contributions in medical innovation. Dr. Solar received his Ph.D. in Biomaterials and Materials Science from the University of Pennsylvania in 1977.

martin b. leon, md
Martin B. Leon, MD, FACC, FESC was a Clinical Professor of Medicine at Georgetown University Medical Center, Washington, DC from 1996-2000, Senior Attending Physician at Lenox Hill Hospital 1999-2004 and is currently Professor of Medicine at Columbia University Medical Center and Associate Director of Cardiovascular Interventional Therapy (CIVT), New York, NY. Dr. Leon was the founder and has been the Chairman of the Cardiovascular Research Foundation (New York City) from 1990 to the present. Dr. Leon has co-authored over 1100 publications, has performed over 7,000 interventional procedures, and has had an important impact in several areas of interventional vascular therapy, including endovascular stents, new device angioplasty with atherectomy and laser techniques, intravascular ultrasound angiogenesis therapies, drug-eluting stents and transcatheter valve therapies. He was the founder and is the Director of Transcatheter Cardiovascular Therapeutics, the largest dedicated meeting in interventional vascular therapy in the world, and he has also directed many other subspecialty meetings and conferences both in the U.S.and internationally. Dr. Leon is a graduate of the Yale School of Medicine, where he also completed formal training in Internal Medicine and Cardiology.

nancy l. moureau, bsn, crni
Nancy Moureau is CEO and founder of PICC Excellence, Inc, an educational company with a primary focus on PICC Training for medical professionals. In addition to training and precepting throughout the United States, Canada and the UK, she works with manufacturers through research, consulting, curriculum and product development. A graduate of East Carolina University in North Carolina, Ms. Moureau has practiced in the areas of vascular access for more than 25 years. She is a clinician, educator and thought leader with numerous publications and presentations both nationally and internationally on PICCs and other issues dealing with infusion therapy.

paul m. goldfarb, md FACS
Dr. Goldfarb is a surgical oncologist with over 20 years clinical experience. He has been President of the California Division of the American Cancer Society and is a Clinical Professor of Surgery at University of California in San Diego. He has been affiliated with Scripps Mercy, Sharp Community, Grossmont, Alvarado, Coronado, and U.C.S.D. Thornton hospitals. He has also been a Fellow with the American College of Surgeons and a Member of the Society of Surgical Oncology and Society of Head and Neck Surgeons. He has consulted for several medical device and biotechnology companies helping to address issues of regulatory strategy as well as develop clinical trials for FDA and European regulatory approval and has testified at several FDA sponsored meetings on combination product approval.

next >